IRCT2016062328603N1
Completed
Phase 2
Study of the effectiveness of a combination of methadone treatment with group treatment based on Acceptance & Commitment therapy (ACT) versus methadone treatment in the prevention rate of relapse in people with abuse opioids.
Vice chancellor for research Zanjan University of Medical Sciences0 sites30 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Mental & behavioural disorders due to use of opioids.
- Sponsor
- Vice chancellor for research Zanjan University of Medical Sciences
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Having informed consent to participate in research; Taking at least two weeks Methadone; Being male; Having a minimum of 18 \& maximum of 45 years old. Exclusion criteria: Patient will be deleted after the two meeting absence; More severe problems, such as suicidal thoughts or have psychotic disorders
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
To evaluate the efficacy of two drugs methylprednisolone and etoricoxib in laproscopic surgeryHealth Condition 1: O- Medical and SurgicalCTRI/2019/03/018041Department of anaesthesiology Jln Medical College ajmer
Recruiting
Phase 1
This is a phase 2, randomized, double blind, multicenter study evaluating the efficacy and safety of the combination of methotrexate plus UVB TL01 in vitiligo.Vitiligo with new lesions or extension of old lesions during the last 6 monthsTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]CTIS2024-512766-34-00Centre Hospitalier Universitaire De Bordeaux48
Completed
Phase 4
A clinical trial to study the effects of two drugs, Metformin Immediate Release and Metformin Extended Release in newly diagnosed type 2 diabetes mellitus patients.Health Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2021/04/033194Bangalore Medical College and Research Institute70
Active, not recruiting
Not Applicable
To evaluate the effectiveness of MetaDerm Cream in Atopic DermatitisCTRI/2017/06/008950Haus Bioceuticals Inc
Completed
Not Applicable
A Phase II Randomised Study of the Addition of Methotrexate 0.05 mg/kg 12 hourly for 8 doses to the Current Immunosuppressant Regimen for the Prevention of Liver Allograft Rejection.ISRCTN58758525Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)60